chr15-42753175-C-T
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_173500.4(TTBK2):c.2071G>A(p.Glu691Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000181 in 1,606,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_173500.4 missense
Scores
Clinical Significance
Conservation
Publications
- spinocerebellar ataxia type 11Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152198Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000166 AC: 4AN: 240630 AF XY: 0.00000766 show subpopulations
GnomAD4 exome AF: 0.00000619 AC: 9AN: 1454046Hom.: 0 Cov.: 32 AF XY: 0.00000553 AC XY: 4AN XY: 723212 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000131 AC: 20AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74364 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.2071G>A (p.E691K) alteration is located in exon 14 (coding exon 13) of the TTBK2 gene. This alteration results from a G to A substitution at nucleotide position 2071, causing the glutamic acid (E) at amino acid position 691 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at